Delivery Order SPE2DB22D2206-SPE2DB25FDS58
Award Date
10/9/24
Potential Completion Date
10/31/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,042.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product, with a completion date of July 2, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order as a delivery order contract, with a firm fixed price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,460.92, is for the delivery of MEKINIST 0.05 MG/ML SOLUTION 90ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $5,053.45, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565442229 - MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product, with a completion date of September 4, 2024. The contract type is Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,460.92 firm fixed-price delivery order is for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,468.49, is for the delivery of the drug MEKINIST 2 MG TABLET in 30-tablet units. This is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of up to $999,999,999 and runs through December 2025. The contract does...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,589.70 for the provision of MEKINIST 0.5 MG TABLET medical products. The award was made on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 28, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of medical supplies, including the drug MEKINIST 2MG TAB 30S. The contract has a firm fixed price of $18,371.32 and runs through January 27, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MEKINIST 2 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $9,185.66 and an ultimate completion date of January 23, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,878.79 firm fixed-price delivery order is for the drug MEKINIST 2 MG TABLET, with a completion date of July 16, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,318.41, is for the delivery of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The award does not have a set-aside designation, indicating open competition....